Your browser doesn't support javascript.
loading
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.
Benafif, Sarah; Ni Raghallaigh, Holly; McGrowder, Eva; Saunders, Edward J; Brook, Mark N; Saya, Sibel; Rageevakumar, Reshma; Wakerell, Sarah; James, Denzil; Chamberlain, Anthony; Taylor, Natalie; Hogben, Matthew; Benton, Barbara; D'Mello, Lucia; Myhill, Kathryn; Mikropoulos, Christos; Bowen-Perkins, Hywel; Rafi, Imran; Ferris, Michelle; Beattie, Andre; Kuganolipava, Shophia; Sevenoaks, Tamsin; Bower, Juliet; Kumar, Pardeep; Hazell, Steven; deSouza, Nandita M; Antoniou, Antonis; Bancroft, Elizabeth; Kote-Jarai, Zsofia; Eeles, Rosalind.
Afiliação
  • Benafif S; Oncogenetics Team, Institute of Cancer Research, London, UK.
  • Ni Raghallaigh H; Oncogenetics Team, Institute of Cancer Research, London, UK.
  • McGrowder E; Oncogenetics Team, Institute of Cancer Research, London, UK.
  • Saunders EJ; Oncogenetics Team, Institute of Cancer Research, London, UK.
  • Brook MN; Oncogenetics Team, Institute of Cancer Research, London, UK.
  • Saya S; Oncogenetics Team, Institute of Cancer Research, London, UK.
  • Rageevakumar R; The University of Melbourne, Melbourne, Victoria, Australia.
  • Wakerell S; Oncogenetics Team, Institute of Cancer Research, London, UK.
  • James D; Oncogenetics Team, Institute of Cancer Research, London, UK.
  • Chamberlain A; Oncogenetics Team, Institute of Cancer Research, London, UK.
  • Taylor N; Oncogenetics Team, Institute of Cancer Research, London, UK.
  • Hogben M; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Benton B; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • D'Mello L; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Myhill K; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Mikropoulos C; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Bowen-Perkins H; Royal Surrey County Hospital NHS Foundation Trust, Surrey, UK.
  • Rafi I; Shadbolt Park House Surgery, Worcester Park, UK.
  • Ferris M; The Longcroft Clinic, Banstead, UK.
  • Beattie A; Lane End Medical Group, Edgware, UK.
  • Kuganolipava S; Dorking Medical Practice, Dorking, UK.
  • Sevenoaks T; Medwyn Surgery, Dorking, UK.
  • Bower J; Brockwood Medical Practice, Dorking, UK.
  • Kumar P; Leith Hill Practice, Dorking, UK.
  • Hazell S; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • deSouza NM; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Antoniou A; Magnetic Resonance Team, Institute of Cancer Research, London, UK.
  • Bancroft E; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Kote-Jarai Z; Oncogenetics Team, Institute of Cancer Research, London, UK.
  • Eeles R; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK.
BJU Int ; 129(3): 325-336, 2022 03.
Article em En | MEDLINE | ID: mdl-34214236
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Polimorfismo de Nucleotídeo Único Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Polimorfismo de Nucleotídeo Único Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article